LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 171

Search options

  1. Article ; Online: DNA Methylation Dysfunction in Chronic Kidney Disease.

    Ingrosso, Diego / Perna, Alessandra F

    Genes

    2020  Volume 11, Issue 7

    Abstract: Renal disease is the common denominator of a number of underlying disease conditions, whose prevalence has been dramatically increasing over the last two decades. Two aspects are particularly relevant to the subject of this review: (I) most cases are ... ...

    Abstract Renal disease is the common denominator of a number of underlying disease conditions, whose prevalence has been dramatically increasing over the last two decades. Two aspects are particularly relevant to the subject of this review: (I) most cases are gathered under the umbrella of chronic kidney disease since they require-predictably for several lustrums-continuous clinical monitoring and treatment to slow down disease progression and prevent complications; (II) cardiovascular disease is a terrible burden in this population of patients, in that it claims many lives yearly, while only a scant minority reach the renal disease end stage. Why indeed a review on DNA methylation and renal disease? As we hope to convince you, the present evidence supports the role of the existence of various derangements of the epigenetic control of gene expression in renal disease, which hold the potential to improve our ability, in the future, to more effectively act toward disease progression, predict outcomes and offer novel therapeutic approaches.
    MeSH term(s) Cardiovascular Diseases/genetics ; Cardiovascular Diseases/pathology ; Cardiovascular Diseases/prevention & control ; DNA Methylation/physiology ; Disease Progression ; Epigenesis, Genetic/physiology ; Humans ; Kidney Failure, Chronic/genetics ; Kidney Failure, Chronic/metabolism ; Kidney Failure, Chronic/pathology ; Kidney Failure, Chronic/prevention & control ; Prognosis ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/therapy ; Therapies, Investigational/methods ; Therapies, Investigational/trends
    Language English
    Publishing date 2020-07-16
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527218-4
    ISSN 2073-4425 ; 2073-4425
    ISSN (online) 2073-4425
    ISSN 2073-4425
    DOI 10.3390/genes11070811
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Homocysteine and chronic kidney disease: an ongoing narrative.

    Perna, Alessandra F / Ingrosso, Diego

    Journal of nephrology

    2019  Volume 32, Issue 5, Page(s) 673–675

    MeSH term(s) Homocysteine/metabolism ; Humans ; Renal Insufficiency, Chronic/metabolism
    Chemical Substances Homocysteine (0LVT1QZ0BA)
    Language English
    Publishing date 2019-06-21
    Publishing country Italy
    Document type Editorial
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-019-00622-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy?

    García-Martínez, Yuselys / Borriello, Margherita / Capolongo, Giovanna / Ingrosso, Diego / Perna, Alessandra F

    Biology

    2023  Volume 12, Issue 2

    Abstract: Kidney transplantation improves quality of life, morbidity, and mortality of patients with kidney failure. However, integrated immunosuppressive therapy required to preserve graft function is associated with the development of post-transplant ... ...

    Abstract Kidney transplantation improves quality of life, morbidity, and mortality of patients with kidney failure. However, integrated immunosuppressive therapy required to preserve graft function is associated with the development of post-transplant complications, including infections, altered immunosuppressive metabolism, gastrointestinal toxicity, and diarrhea. The gut microbiota has emerged as a potential therapeutic target for personalizing immunosuppressive therapy and managing post-transplant complications. This review reports current evidence on gut microbial dysbiosis in kidney transplant recipients, alterations in their gut microbiota associated with kidney transplantation outcomes, and the application of gut microbiota intervention therapies in treating post-transplant complications.
    Language English
    Publishing date 2023-01-20
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2661517-4
    ISSN 2079-7737
    ISSN 2079-7737
    DOI 10.3390/biology12020163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: [Hyponatremia and Electrolyte Disorders in Cancer Patients].

    Florio, Giulia / Iervolino, Anna / Simeoni, Mariadelina / Perna, Alessandra F / Trepiccione, Francesco

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

    2023  Volume 40, Issue Suppl 81

    Abstract: Onconephrology is a rising and rapidly expanding field of medicine in which nephrology and oncology meet each other. Besides multidisciplinary meetings, oncologists and nephrologists often discuss on timing of the treatment, dosage, and side effects ... ...

    Abstract Onconephrology is a rising and rapidly expanding field of medicine in which nephrology and oncology meet each other. Besides multidisciplinary meetings, oncologists and nephrologists often discuss on timing of the treatment, dosage, and side effects management. Cancer patients often encounter different electrolyte disorders. They are mostly secondary to the tumor itself or consequences of its treatment. In the last years, the great efforts to find new therapies like targeted, immune, and cell-based led us to many new side effects. Hyponatremia, hypokalemia, hyperkalemia, hypercalcemia, and hypomagnesemia are among the most common electrolyte disorders. Data have shown a worse prognosis in patients with electrolytic imbalances. Additionally, they cause a delay in chemotherapy or even an interruption. It is important to diagnose promptly these complications and treat them. In this review, we provide a special focus on hyponatremia and its treatment as the most common electrolytes disorder in cancer patients, but also on newly described cases of hypo- and hyperkalemia and metabolic acidosis.
    MeSH term(s) Humans ; Hyponatremia/diagnosis ; Hyponatremia/etiology ; Hyponatremia/therapy ; Hyperkalemia/therapy ; Hyperkalemia/complications ; Hypernatremia/complications ; Water-Electrolyte Imbalance/etiology ; Neoplasms/complications ; Hypokalemia/etiology ; Electrolytes
    Chemical Substances Electrolytes
    Language Italian
    Publishing date 2023-10-03
    Publishing country Italy
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 1237110-5
    ISSN 1724-5990 ; 0393-5590
    ISSN (online) 1724-5990
    ISSN 0393-5590
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Secondary Hyperparathyroidism and Hypertension: An Intriguing Couple.

    Simeoni, Mariadelina / Perna, Alessandra F / Fuiano, Giorgio

    Journal of clinical medicine

    2020  Volume 9, Issue 3

    Abstract: ...

    Abstract :
    Language English
    Publishing date 2020-02-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm9030629
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy?

    García-Martínez, Yuselys / Borriello, Margherita / Capolongo, Giovanna / Ingrosso, Diego / Perna, Alessandra F.

    Biology (Basel). 2023 Jan. 20, v. 12, no. 2

    2023  

    Abstract: Kidney transplantation improves quality of life, morbidity, and mortality of patients with kidney failure. However, integrated immunosuppressive therapy required to preserve graft function is associated with the development of post-transplant ... ...

    Abstract Kidney transplantation improves quality of life, morbidity, and mortality of patients with kidney failure. However, integrated immunosuppressive therapy required to preserve graft function is associated with the development of post-transplant complications, including infections, altered immunosuppressive metabolism, gastrointestinal toxicity, and diarrhea. The gut microbiota has emerged as a potential therapeutic target for personalizing immunosuppressive therapy and managing post-transplant complications. This review reports current evidence on gut microbial dysbiosis in kidney transplant recipients, alterations in their gut microbiota associated with kidney transplantation outcomes, and the application of gut microbiota intervention therapies in treating post-transplant complications.
    Keywords diarrhea ; dysbiosis ; gastrointestinal system ; immunosuppression ; intestinal microorganisms ; kidney transplant ; metabolism ; morbidity ; mortality ; quality of life ; renal failure ; toxicity
    Language English
    Dates of publication 2023-0120
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article ; Online
    ZDB-ID 2661517-4
    ISSN 2079-7737
    ISSN 2079-7737
    DOI 10.3390/biology12020163
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Effect of Hydrogen Sulfide on Essential Functions of Polymorphonuclear Leukocytes.

    Farahat, Sarah / Kherkheulidze, Salome / Nopp, Stephan / Kainz, Alexander / Borriello, Margherita / Perna, Alessandra F / Cohen, Gerald

    Toxins

    2023  Volume 15, Issue 3

    Abstract: Impaired polymorphonuclear leukocyte (PMNL) functions contribute to increased infections and cardiovascular diseases in chronic kidney disease (CKD). Uremic toxins reduce hydrogen sulfide ( ... ...

    Abstract Impaired polymorphonuclear leukocyte (PMNL) functions contribute to increased infections and cardiovascular diseases in chronic kidney disease (CKD). Uremic toxins reduce hydrogen sulfide (H
    MeSH term(s) Cysteine/pharmacology ; Cysteine/metabolism ; Escherichia coli ; Hydrogen Sulfide/pharmacology ; Hydrogen Sulfide/metabolism ; Neutrophils ; Phosphatidylinositol 3-Kinases/metabolism
    Chemical Substances Cysteine (K848JZ4886) ; diallyl trisulfide (0ZO1U5A3XX) ; GYY 4137 ; Hydrogen Sulfide (YY9FVM7NSN) ; Phosphatidylinositol 3-Kinases (EC 2.7.1.-) ; sodium bisulfide (FWU2KQ177W) ; sodium sulfide (YGR27ZW0Y7) ; diallyl disulfide (5HI47O6OA7)
    Language English
    Publishing date 2023-03-04
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518395-3
    ISSN 2072-6651 ; 2072-6651
    ISSN (online) 2072-6651
    ISSN 2072-6651
    DOI 10.3390/toxins15030198
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: [Methods for calculating the number of nephrons from ultrasound scans and kidney biopsies for nephrologists' use].

    Borriello, Gianmarco / Gravina, Ilenia / Perna, Alessandra F / Viggiano, Davide / Pollastro, Rosa Maria

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

    2022  Volume 39, Issue 6

    Abstract: The interest in determining the number of nephrons in the kidney dates back to the 1960s, when an influential laboratory method for determining ex vivo the number of nephrons in the kidneys was described by Bricker. Over the years, various methods have ... ...

    Abstract The interest in determining the number of nephrons in the kidney dates back to the 1960s, when an influential laboratory method for determining ex vivo the number of nephrons in the kidneys was described by Bricker. Over the years, various methods have been developed to estimate the number of nephrons in living beings as accurately as possible. These modern methods combine data such as the glomerular density, the percentage of glomeruli in sclerosis calculated from biopsy samples, and the kidney volume, which can be precisely estimated from magnetic resonance, CT scan, or specific ultrasound methods. As the reduction in the number of functioning nephrons is closely connected with an increased risk of progression of renal disease (especially in patients with nephrotic syndrome) and hypertension, its introduction into clinical practice could allow a precise stratification of progression risk in patients with kidney disease and a better understanding of the mechanisms that contribute to the loss of functioning nephrons.
    MeSH term(s) Humans ; Nephrologists ; Nephrons ; Kidney/diagnostic imaging ; Kidney/pathology ; Kidney Glomerulus/pathology ; Kidney Diseases/diagnostic imaging ; Kidney Diseases/pathology ; Biopsy
    Language Italian
    Publishing date 2022-12-21
    Publishing country Italy
    Document type English Abstract ; Journal Article
    ZDB-ID 1237110-5
    ISSN 1724-5990 ; 0393-5590
    ISSN (online) 1724-5990
    ISSN 0393-5590
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins.

    Coppola, Annapaola / Lombari, Patrizia / Mazzella, Elvira / Capolongo, Giovanna / Simeoni, Mariadelina / Perna, Alessandra F / Ingrosso, Diego / Borriello, Margherita

    International journal of molecular sciences

    2023  Volume 24, Issue 6

    Abstract: Chronic kidney disease (CKD) is an increasing health care problem. About 10% of the general population is affected by CKD, representing the sixth cause of death in the world. Cardiovascular events are the main mortality cause in CKD, with a ... ...

    Abstract Chronic kidney disease (CKD) is an increasing health care problem. About 10% of the general population is affected by CKD, representing the sixth cause of death in the world. Cardiovascular events are the main mortality cause in CKD, with a cardiovascular risk 10 times higher in these patients than the rate observed in healthy subjects. The gradual decline of the kidney leads to the accumulation of uremic solutes with a negative effect on every organ, especially on the cardiovascular system. Mammalian models, sharing structural and functional similarities with humans, have been widely used to study cardiovascular disease mechanisms and test new therapies, but many of them are rather expensive and difficult to manipulate. Over the last few decades, zebrafish has become a powerful non-mammalian model to study alterations associated with human disease. The high conservation of gene function, low cost, small size, rapid growth, and easiness of genetic manipulation are just some of the features of this experimental model. More specifically, embryonic cardiac development and physiological responses to exposure to numerous toxin substances are similar to those observed in mammals, making zebrafish an ideal model to study cardiac development, toxicity, and cardiovascular disease.
    MeSH term(s) Animals ; Humans ; Uremic Toxins ; Zebrafish/physiology ; Toxins, Biological/toxicity ; Uremia/complications ; Cardiovascular Diseases/complications ; Renal Insufficiency, Chronic/complications ; Heart ; Mammals
    Chemical Substances Uremic Toxins ; Toxins, Biological
    Language English
    Publishing date 2023-03-16
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24065656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Secondary Hyperparathyroidism and Hypertension

    Mariadelina Simeoni / Alessandra F. Perna / Giorgio Fuiano

    Journal of Clinical Medicine, Vol 9, Iss 3, p

    An Intriguing Couple

    2020  Volume 629

    Abstract: Secondary hyperparathyroidism (SHPTH) is a major complication in patients on maintenance hemodialysis burdened with high cardiovascular risk. Hypertension is also a high prevalence complication contributing to an increase in the mortality rate in ... ...

    Abstract : Secondary hyperparathyroidism (SHPTH) is a major complication in patients on maintenance hemodialysis burdened with high cardiovascular risk. Hypertension is also a high prevalence complication contributing to an increase in the mortality rate in hemodialysis patients. A possible association between SHPTH and hypertension has been widely reported in the literature and several pathogenetic mechanisms have been described. There is evidence that the decrease of plasma iPTH levels are correlated with hypertension correction in hemodialysis patients undergoing parathyroidectomy and oral calcimimetics administration. We have observed a similar behaviour also in a patient on chronic hemodialysis treated with Etelcalcetide. Even if this is an isolated observation, it could stimulate future investigation, possibly in dedicated clinical trials.
    Keywords secondary hyperparathyroidism ; hypertension ; hemodialysis ; calcimimetic ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2020-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top